HCAT Health Catalyst Inc

Price (delayed)

$56.87

Market cap

$2.53B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.08

Enterprise value

$2.6B

Highlights
The company's revenue rose by 21% YoY and by 6% QoQ
The company's gross profit rose by 19% YoY and by 8% QoQ
HCAT's EPS has soared by 84% year-on-year but it is down by 6% since the previous quarter
The net income has plunged by 97% YoY and by 9% from the previous quarter
Health Catalyst's quick ratio has plunged by 67% from the previous quarter and by 67% YoY

Key stats

What are the main financial stats of HCAT
Market
Shares outstanding
44.52M
Market cap
$2.53B
Enterprise value
$2.6B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
9.32
Price to sales (P/S)
12.5
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
13.01
Earnings
Revenue
$199.58M
EBIT
-$110.85M
EBITDA
-$81.92M
Free cash flow
-$27.99M
Per share
EPS
-$3.08
Free cash flow per share
-$0.64
Book value per share
$6.1
Revenue per share
$4.55
TBVPS
$8.47
Balance sheet
Total assets
$571.22M
Total liabilities
$302.38M
Debt
$197.4M
Equity
$268.84M
Working capital
$65.32M
Liquidity
Debt to equity
0.73
Current ratio
1.25
Quick ratio
1.2
Net debt/EBITDA
-0.79
Margins
EBITDA margin
-41%
Gross margin
49.2%
Net margin
-63.1%
Operating margin
-51.3%
Efficiency
Return on assets
-23%
Return on equity
-46.7%
Return on invested capital
-32.1%
Return on capital employed
-35.6%
Return on sales
-55.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

HCAT stock price

How has the Health Catalyst stock price performed over time
Intraday
1.64%
1 week
-1.71%
1 month
0.34%
1 year
56.24%
YTD
30.65%
QTD
2.45%

Financial performance

How have Health Catalyst's revenue and profit performed over time
Revenue
$199.58M
Gross profit
$98.23M
Operating income
-$102.34M
Net income
-$125.9M
Gross margin
49.2%
Net margin
-63.1%
The net income has plunged by 97% YoY and by 9% from the previous quarter
The operating income has dropped by 65% year-on-year and by 6% since the previous quarter
The company's net margin has shrunk by 63% YoY and by 3.6% QoQ
The operating margin fell by 37% YoY

Growth

What is Health Catalyst's growth rate over time

Valuation

What is Health Catalyst stock price valuation
P/E
N/A
P/B
9.32
P/S
12.5
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
13.01
HCAT's EPS has soared by 84% year-on-year but it is down by 6% since the previous quarter
HCAT's price to book (P/B) is 53% higher than its last 4 quarters average of 6.0
The company's equity fell by 2.6% QoQ and by 2.6% YoY
The stock's price to sales (P/S) is 45% more than its last 4 quarters average of 8.5
The company's revenue rose by 21% YoY and by 6% QoQ

Efficiency

How efficient is Health Catalyst business performance
Health Catalyst's return on assets has surged by 53% YoY but it has decreased by 10% QoQ
The ROIC has plunged by 51% YoY and by 22% from the previous quarter
HCAT's ROS is down by 48% year-on-year
HCAT's return on equity is up by 43% year-on-year but it is down by 10% since the previous quarter

Dividends

What is HCAT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for HCAT.

Financial health

How did Health Catalyst financials performed over time
HCAT's total assets is 89% greater than its total liabilities
The current ratio has plunged by 67% from the previous quarter and by 67% YoY
Health Catalyst's quick ratio has plunged by 67% from the previous quarter and by 67% YoY
The company's debt is 27% lower than its equity
The debt to equity is up by 2.8% since the previous quarter and by 2.8% year-on-year
The company's equity fell by 2.6% QoQ and by 2.6% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.